Skip to main content
. 2014 Oct 13;9(10):e109623. doi: 10.1371/journal.pone.0109623

Figure 12. Optimal dosing based on 6-TGN concentration as therapeutic target.

Figure 12

A & B. Optimal 6-TGN concentration and optimal 6-MP regimen respectively, for a patient with low TPMT enzyme activity. C & D. Optimal profiles for a patient with high TPMT enzyme activity. Patient with low TPMT activity required significantly lower dose compared to the standard treatment and vice versa. Dashed line shows the therapeutic target level.